Synlogic Inc (SYBX)
1.88
+0.05
(+2.73%)
USD |
NASDAQ |
Apr 19, 16:00
1.88
0.00 (0.00%)
After-Hours: 20:00
Synlogic Research and Development Expense (Quarterly): 10.14M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.14M |
| September 30, 2023 | 9.616M |
| June 30, 2023 | 11.76M |
| March 31, 2023 | 12.45M |
| December 31, 2022 | 13.64M |
| September 30, 2022 | 14.61M |
| June 30, 2022 | 12.06M |
| March 31, 2022 | 11.74M |
| December 31, 2021 | 11.87M |
| September 30, 2021 | 13.36M |
| June 30, 2021 | 10.72M |
| March 31, 2021 | 11.18M |
| December 31, 2020 | 11.41M |
| September 30, 2020 | 10.48M |
| June 30, 2020 | 12.91M |
| March 31, 2020 | 12.68M |
| December 31, 2019 | 11.25M |
| September 30, 2019 | 10.56M |
| June 30, 2019 | 9.703M |
| Date | Value |
|---|---|
| March 31, 2019 | 10.38M |
| December 31, 2018 | 8.867M |
| September 30, 2018 | 9.934M |
| June 30, 2018 | 10.87M |
| March 31, 2018 | 8.361M |
| December 31, 2017 | 7.736M |
| September 30, 2017 | 8.955M |
| June 30, 2017 | 5.079M |
| March 31, 2017 | 0.242M |
| December 31, 2016 | 2.341M |
| September 30, 2016 | 3.384M |
| June 30, 2016 | 3.682M |
| March 31, 2016 | 4.523M |
| December 31, 2015 | 6.363M |
| September 30, 2015 | 4.683M |
| June 30, 2015 | 4.499M |
| March 31, 2015 | 3.402M |
| December 31, 2014 | 3.51M |
| September 30, 2014 | 2.788M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
9.616M
Minimum
Sep 2023
14.61M
Maximum
Sep 2022
11.69M
Average
11.74M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| BioXcel Therapeutics Inc | 9.934M |
| Inotiv Inc | -- |
| IGM Biosciences Inc | 54.19M |
| Humacyte Inc | 20.18M |
| Moderna Inc | 1.406B |